Authors:
Schmalfeldt, B
Prechtel, D
Harting, K
Spathe, K
Rutke, S
Konik, E
Fridman, R
Berger, U
Schmitt, M
Kuhn, W
Lengyel, E
Citation: B. Schmalfeldt et al., Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer, CLIN CANC R, 7(8), 2001, pp. 2396-2404
Authors:
Nicklas, M
Borth, R
Lengyel, E
Pagliuso, PG
Sarrao, JL
Sidorov, VA
Sparn, G
Steglich, F
Thompson, JD
Citation: M. Nicklas et al., Response of the heavy-fermion superconductor CeCoIn5 to pressure: roles ofdimensionality and proximity to a quantum-critical point, J PHYS-COND, 13(44), 2001, pp. L905-L912
Authors:
Hapke, S
Gawaz, M
Dehne, K
Kohler, J
Marshall, JF
Graeff, H
Schmitt, M
Reuning, U
Lengyel, E
Citation: S. Hapke et al., beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in theu-PAR promoter, MOL CELL B, 21(6), 2001, pp. 2118-2132
Authors:
Lengyel, E
Schmalfeldt, B
Konik, E
Spathe, K
Harting, K
Fenn, A
Berger, U
Fridman, R
Schmitt, M
Prechtel, D
Kuhn, W
Citation: E. Lengyel et al., Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer, GYNECOL ONC, 82(2), 2001, pp. 291-298
Authors:
Iesalnieks, I
Rentsch, M
Lengyel, E
Mirwald, T
Jauch, KW
Beham, A
Citation: I. Iesalnieks et al., JNK and p38MAPK are activated during graft reperfusion and not during coldstorage in rat liver transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 931-932
Authors:
Hapke, S
Kessler, H
de Prada, NA
Benge, A
Schmitt, M
Lengyel, E
Reuning, U
Citation: S. Hapke et al., Integrin alpha(v)beta(3)/vitronectin interaction affects expression of theurokinase system in human ovarian cancer cells, J BIOL CHEM, 276(28), 2001, pp. 26340-26348
Authors:
Gerhard, M
Neumayer, N
Presecan-Siedel, E
Zanner, R
Lengyel, E
Cramer, T
Hocker, M
Prinz, C
Citation: M. Gerhard et al., Gastrin induces expression and promoter activity of the vesicular monoamine transporter subtype 2, ENDOCRINOL, 142(8), 2001, pp. 3663-3672
Authors:
Dickfeld, T
Lengyel, E
May, AE
Massberg, S
Brand, K
Page, S
Thielen, C
Langenbrink, K
Gawaz, M
Citation: T. Dickfeld et al., Transient interaction of activated platelets with endothelial cells induces expression of monocyte-chemoattractant protein-1 via a p38 mitogen-activated protein kinase mediated pathway: Implications for atherogenesis, CARDIO RES, 49(1), 2001, pp. 189-199
Authors:
Schmitt, M
Wilhelm, OG
Reuning, U
Kruger, A
Harbeck, N
Lengyel, E
Graeff, H
Gansbacher, B
Kessler, H
Burgle, M
Sturzebecher, J
Sperl, S
Magdolen, V
Citation: M. Schmitt et al., The urokinase plasminogen activator system as a novel target for tumour therapy, FIBRINOL PR, 14(2-3), 2000, pp. 114-132
Authors:
Schnelzer, A
Prechtel, D
Knaus, U
Dehne, K
Gerhard, M
Graeff, H
Harbeck, N
Schmitt, M
Lengyel, E
Citation: A. Schnelzer et al., Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b, ONCOGENE, 19(26), 2000, pp. 3013-3020
Authors:
Lengyel, E
Somogyi, A
Godeny, M
Szerdahelyi, A
Nemeth, G
Citation: E. Lengyel et al., Polymorphous low-grade adenocarcinoma of the nasopharynx - Case report andreview of the literature, STRAH ONKOL, 176(1), 2000, pp. 40-42
Authors:
Hannke-Lohmann, A
Von Steinburg, SP
Dehne, K
Benard, V
Kolben, M
Schmitt, M
Lengyel, E
Citation: A. Hannke-lohmann et al., Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia, OBSTET GYN, 96(4), 2000, pp. 582-587
Authors:
Ried, S
Jager, C
Jeffers, M
Vande Woude, GF
Graeff, H
Schmitt, M
Lengyel, E
Citation: S. Ried et al., Activation mechanisms of the urokinase-type plasminogen activator promoterby hepatocyte growth factor scatter factor, J BIOL CHEM, 274(23), 1999, pp. 16377-16386